Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Clinician,Infliximab,Crohn's disease and ulcerative colitis - widening access (dose escalation),Infliximab,Options for investment,,Alimentary Tract and Metabolism
